References
- Cherry JD. Pertussis in young infants throughout the world. Clin Infect Dis. 2016;63(suppl 4):S119–22.
- WHO. Pertussis vaccines: WHO position paper. Wkly Epidemiol Rec. 2010;85(40):385–400.
- Kuchar E, Karlikowska-Skwarnik M, Han S, et al. Pertussis: History of the disease and current prevention failure. Adv Exp Med Biol. 2016;934:77–82.
- Yinghua X, Tan Y, Asokanathan C, et al. Characterization of co-purified acellular pertussis vaccines. Hum Vaccin Immunother. 2015;11(2):421–427.
- Wang L, Lei D, Zhang S. Acellular pertussis vaccines in China. Vaccine. 2012;30(50):7174–7178. 26.
- Liu Z, Liu S, Shu Y, et al. Severe Bordetella pertussis infection and vaccine issue in Chongqing, from 2012 to 2018. Int J Infect Dis. 2019;84:102–108.
- Meng Q, Li L, Shi W, et al. Seroprevalence of diphtheria and pertussis immunoglobulin G among children with pneumonia in Ji’nan, China. BMC Pediatr. 2018;18(1):383.
- Yang Y, Yao K, Xiang M, et al. Variation in bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970-2014). PloS One. 2015;10(9):e0138941.
- Nin GJ, Gao Y, Wang D, et al. Epidemiology of pertussis in China, 2011-2017. 2018;24:264–267. Chin J Vaccines Immunization.
- Meng Q, Qian Q, Li L, et al. The maternal antibody against diphtheria, tetanus and pertussis showed distinct regional difference in China. BMC Pediatr. 2019;19(1):480.
- Guiso N. Wirsing von König CH. Surveillance of pertussis: methods and implementation. Expert Rev Anti Infect Ther. 2016;14(7):657–667.
- Zouari A, Smaoui H, Kechrid A. The diagnosis of pertussis: which method to choose? Crit Rev Microbiol. 2012;38(2):111–21.
- Fine PE, Clarkson JA. Seasonal influences on pertussis. Int J Epidemiol. 1986;15(2):237–247.
- Skoff TH, Hadler S, Hariri S. The epidemiology of nationally reported pertussis in the United States, 2000-2016. Clin Infect Dis. 2018;68(10):1634–1640.
- Leong R, Wood JG, Turner RM, et al. Estimating seasonal variation in Australian pertussis notifications from 1991 to 2016: evidence of spring to summer peaks. Epidemiol Infect. 2019;147:e155.
- Korppi M, Hiltunen J. Pertussis is common in nonvaccinated infants hospitalized for respiratory syncytial virus infection. Pediatr Infect Dis J. 2007;26(4):316–318.
- Saiki-Macedo S, Valverde-Ezeta J, Cornejo-Tapia A, et al. Identfication of viral and bacterial etiologic agents of the pertussis-like syndrome in children under 5 years old hospitalized. BMC Infect Dis. 2019;19(1):75. 21.
- Mahmoudi S, Banar M, Pourakbari B, et al. Identification of etiologic agents of the pertussis-like syndrome in children by real-time PCR method. Prague Med Rep. 2018;119(1):61–69.
- Tao Y, Tang M, Luo L. Identification of etiologic agents and clinical characteristics for patients suspected of having pertussis in a large Children’s hospital in China. Ann Transl Med. 2019;7(18):443.
- Martinón-Torres F, Heininger U, Thomson A, et al. pertussis: how can we do it? A focus on immunization. Expert Rev Vaccines. 2018;17(4):289–297.
- Campbell H, Gupta S, Dolan GP, et al. Review of vaccination in pregnancy to prevent pertussis in early infancy. J Med Microbiol. 2018;67(10):1426–1456.
- Loubet P, Anselem O, Launay O. Immunization during pregnancy. Expert Rev Vaccines. 2018;17(5):383–393.
- Agopian A, Young H, Quinlan S, et al. of childhood vaccinations in Armenia, 2015-2016. Vaccine. 2020;38(30):4671–4678.
- Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:326–382.
- Cherry JD. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr. 1984;14(2):1–78.
- Skowronski DM, De Serres G, MacDonald D, et al. The changing age and seasonal profile of pertussis in Canada. J Infect Dis. 2002;185(10):1448–1453.
- Lijun L, Deng J, Xiang M, et al. High Prevalence of Macrolide-Resistant Bordetella pertussis and ptxP1 Genotype, Mainland China, 2014-2016. Emerg Infect Dis. 2019;25(12):2205–2214. 12.
- Hua C-Z, Wang H-J, Zhang Z, et al. In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolates: a single-centre study in Zhejiang Province, China. J Glob Antimicrob Resist. 09 2019;18: 47–51.
- Kamachi K, Duong HT, Dang AD, et al. Macrolide-resistant bordetella pertussis, Vietnam, 2016-2017. Emerg Infect Dis. 2020;26(10):2511–2513.
- He Q, Viljanen MK, Arvilommi H, et al. Whooping cough caused by bordetella pertussis and bordetella parapertussis in an immunized population. JAMA. 1998;280(7):635–637.
- Liese JG, Renner C, Stojanov S, et al. Clinical and epidemiological picture of B pertussis and B parapertussis infections after introduction of acellular pertussis vaccines. Arch Dis Child. 2003;88(8):684–687.
- Ducours M, Rispal P, Danjean MP, et al. Bordetella bronchiseptica infection. Med Mal Infect. 2017;47(7):453–458.
- Pittet LF, Emonet S, Schrenzel J, et al. Bordetella holmesii: an under-recognised Bordetella species. Lancet Infect Dis. 2014;14(6):510–519.
- Li Y, Yuan L, Wang Q, et al. study on clinical epidemiological characteristics and diagnostic methods of pertussis. Mol Diagn Ther. 2019;4:263–267.
- Tatti KM, Sparks KN, Boney KO, et al. Novel multitarget real-time PCR assay for rapid detection of Bordetella species in clinical specimens. J Clin Microbiol. 2011;49(12):4059–4066.